Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Morton

Showing results (891-900 of 1,110) with videos related to

Pageof 111
Sort By:
The Australasian Journal of Dermatology|August 2, 2016
Diagnosis and clinical management of melanoma patients at higher risk of a new primary melanoma: A population-based study in New South Wales, AustraliaCaroline G Watts, Christine M Madronio, Rachael L Morton, et al.
Cancer Gene Therapy|January 12, 2008
An improved human carboxylesterase for enzyme/prodrug therapy with CPT-11M Wierdl, L Tsurkan, J L Hyatt, et al.
Nature Reviews. Nephrology|May 31, 2017
Reducing the costs of chronic kidney disease while delivering quality health care: a call to actionRaymond Vanholder, Lieven Annemans, Edwina Brown, et al.
Experimental Neurology|April 15, 2004
Environmental, pharmacological, and genetic modulation of the HD phenotype in transgenic miceGabriele Schilling, Alena V Savonenko, Michael L Coonfield, et al.
Pediatric Blood & Cancer|April 11, 2007
Initial testing (stage 1) of the proteasome inhibitor bortezomib by the pediatric preclinical testing programPeter J Houghton, Christopher L Morton, E Anders Kolb, et al.
Pediatric Blood & Cancer|February 23, 2008
Initial testing (stage 1) of sunitinib by the pediatric preclinical testing programJohn M Maris, Joshua Courtright, Peter J Houghton, et al.
The Journal of Investigative Dermatology|March 10, 2012
AIM1 and LINE-1 epigenetic aberrations in tumor and serum relate to melanoma progression and disease outcomeSojun Hoshimoto, Christine T Kuo, Kelly K Chong, et al.
Cancer|October 1, 1984
Imaging of human tumor xenografts in nude mice with radiolabeled monoclonal antibodies. Limitations of specificity due to nonspecific uptake of antibodyB D Mann, M B Cohen, R E Saxton, et al.
Nature Nanotechnology|June 25, 2013
Atomic clock transitions in silicon-based spin qubitsGary Wolfowicz, Alexei M Tyryshkin, Richard E George, et al.
Nature|February 16, 2016
Controlling spin relaxation with a cavityA Bienfait, J J Pla, Y Kubo, et al.
Pageof 111

Showing results (891-900 of 1,110) with videos related to

Sort By:
Pageof 111
The Australasian Journal of Dermatology|August 2, 2016
Diagnosis and clinical management of melanoma patients at higher risk of a new primary melanoma: A population-based study in New South Wales, AustraliaCaroline G Watts, Christine M Madronio, Rachael L Morton, et al.
Cancer Gene Therapy|January 12, 2008
An improved human carboxylesterase for enzyme/prodrug therapy with CPT-11M Wierdl, L Tsurkan, J L Hyatt, et al.
Nature Reviews. Nephrology|May 31, 2017
Reducing the costs of chronic kidney disease while delivering quality health care: a call to actionRaymond Vanholder, Lieven Annemans, Edwina Brown, et al.
Experimental Neurology|April 15, 2004
Environmental, pharmacological, and genetic modulation of the HD phenotype in transgenic miceGabriele Schilling, Alena V Savonenko, Michael L Coonfield, et al.
Pediatric Blood & Cancer|April 11, 2007
Initial testing (stage 1) of the proteasome inhibitor bortezomib by the pediatric preclinical testing programPeter J Houghton, Christopher L Morton, E Anders Kolb, et al.
Pediatric Blood & Cancer|February 23, 2008
Initial testing (stage 1) of sunitinib by the pediatric preclinical testing programJohn M Maris, Joshua Courtright, Peter J Houghton, et al.
The Journal of Investigative Dermatology|March 10, 2012
AIM1 and LINE-1 epigenetic aberrations in tumor and serum relate to melanoma progression and disease outcomeSojun Hoshimoto, Christine T Kuo, Kelly K Chong, et al.
Cancer|October 1, 1984
Imaging of human tumor xenografts in nude mice with radiolabeled monoclonal antibodies. Limitations of specificity due to nonspecific uptake of antibodyB D Mann, M B Cohen, R E Saxton, et al.
Nature Nanotechnology|June 25, 2013
Atomic clock transitions in silicon-based spin qubitsGary Wolfowicz, Alexei M Tyryshkin, Richard E George, et al.
Nature|February 16, 2016
Controlling spin relaxation with a cavityA Bienfait, J J Pla, Y Kubo, et al.
Pageof 111